Literature DB >> 34103704

Cancer stem cell-immune cell crosstalk in tumour progression.

Defne Bayik1,2, Justin D Lathia3,4.   

Abstract

Cellular heterogeneity and an immunosuppressive tumour microenvironment are independent yet synergistic drivers of tumour progression and underlie therapeutic resistance. Recent studies have highlighted the complex interaction between these cell-intrinsic and cell-extrinsic mechanisms. The reciprocal communication between cancer stem cells (CSCs) and infiltrating immune cell populations in the tumour microenvironment is a paradigm for these interactions. In this Perspective, we discuss the signalling programmes that simultaneously induce CSCs and reprogramme the immune response to facilitate tumour immune evasion, metastasis and recurrence. We further highlight biological factors that can impact the nature of CSC-immune cell communication. Finally, we discuss targeting opportunities for simultaneous regulation of the CSC niche and immunosurveillance.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34103704      PMCID: PMC8740903          DOI: 10.1038/s41568-021-00366-w

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  159 in total

Review 1.  Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.

Authors:  D Ciardiello; E Elez; J Tabernero; J Seoane
Journal:  Ann Oncol       Date:  2020-07-23       Impact factor: 32.976

Review 2.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

Review 3.  Tissue-Resident Macrophage Ontogeny and Homeostasis.

Authors:  Florent Ginhoux; Martin Guilliams
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

Review 4.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

5.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age.

Authors:  Wendy W Pang; Elizabeth A Price; Debashis Sahoo; Isabel Beerman; William J Maloney; Derrick J Rossi; Stanley L Schrier; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

6.  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.

Authors:  Erick Riquelme; Yu Zhang; Liangliang Zhang; Maria Montiel; Michelle Zoltan; Wenli Dong; Pompeyo Quesada; Ismet Sahin; Vidhi Chandra; Anthony San Lucas; Paul Scheet; Hanwen Xu; Samir M Hanash; Lei Feng; Jared K Burks; Kim-Anh Do; Christine B Peterson; Deborah Nejman; Ching-Wei D Tzeng; Michael P Kim; Cynthia L Sears; Nadim Ajami; Joseph Petrosino; Laura D Wood; Anirban Maitra; Ravid Straussman; Matthew Katz; James Robert White; Robert Jenq; Jennifer Wargo; Florencia McAllister
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

7.  Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity.

Authors:  Reza Mirzaei; Susobhan Sarkar; Lauren Dzikowski; Khalil S Rawji; Lubaba Khan; Andreas Faissner; Pinaki Bose; V Wee Yong
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

Review 8.  Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Authors:  Joseph A Clara; Cecilia Monge; Yingzi Yang; Naoko Takebe
Journal:  Nat Rev Clin Oncol       Date:  2019-12-02       Impact factor: 66.675

9.  Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.

Authors:  Shreya Raghavan; Pooja Mehta; Yuying Xie; Yu L Lei; Geeta Mehta
Journal:  J Immunother Cancer       Date:  2019-07-19       Impact factor: 13.751

10.  High-fat diet enhances stemness and tumorigenicity of intestinal progenitors.

Authors:  Semir Beyaz; Miyeko D Mana; Jatin Roper; Dmitriy Kedrin; Assieh Saadatpour; Sue-Jean Hong; Khristian E Bauer-Rowe; Michael E Xifaras; Adam Akkad; Erika Arias; Luca Pinello; Yarden Katz; Shweta Shinagare; Monther Abu-Remaileh; Maria M Mihaylova; Dudley W Lamming; Rizkullah Dogum; Guoji Guo; George W Bell; Martin Selig; G Petur Nielsen; Nitin Gupta; Cristina R Ferrone; Vikram Deshpande; Guo-Cheng Yuan; Stuart H Orkin; David M Sabatini; Ömer H Yilmaz
Journal:  Nature       Date:  2016-03-03       Impact factor: 49.962

View more
  37 in total

Review 1.  Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.

Authors:  Juyeun Lee; Katie Troike; R'ay Fodor; Justin D Lathia
Journal:  Endocrinology       Date:  2022-03-01       Impact factor: 4.736

2.  Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets.

Authors:  Danlei Song; Yongjian Wei; Yuping Hu; Yueting Sun; Min Liu; Qian Ren; Zenan Hu; Qinghong Guo; Yuping Wang; Yongning Zhou
Journal:  Clin Transl Oncol       Date:  2022-01-31       Impact factor: 3.405

Review 3.  The role of lncRNA OIP5-AS1 in cancer development and progression.

Authors:  Cheng Zheng; Man Chu; Qiuli Chen; Cheng Chen; Zhi-Wei Wang; Xiao Chen
Journal:  Apoptosis       Date:  2022-03-22       Impact factor: 4.677

Review 4.  Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.

Authors:  Ritama Paul; Jay F Dorsey; Yi Fan
Journal:  Pharmacol Ther       Date:  2021-09-01       Impact factor: 12.310

5.  NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.

Authors:  Ling-Ling Wang; Xiao-Yun Wan; Tao-Li Wang; Chun-Qi Liu; Fei-Meng Zheng
Journal:  Med Oncol       Date:  2022-10-12       Impact factor: 3.738

6.  BCSCdb: a database of biomarkers of cancer stem cells.

Authors:  Shazia Firdous; Abhirupa Ghosh; Sudipto Saha
Journal:  Database (Oxford)       Date:  2022-09-28       Impact factor: 4.462

Review 7.  The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy.

Authors:  Hiroyuki Takahashi; Gumpei Yoshimatsu; Denise Louise Faustman
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

8.  Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells.

Authors:  Jiaxi Yao; Yue Liu; Jitao Yang; Mengling Li; Simin Li; Bo Zhang; Rui Yang; Yuchong Zhang; Xiaoyu Cui; ChunQing Feng
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

9.  Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment.

Authors:  Hualin Chen; Gang Chen
Journal:  Front Genet       Date:  2022-06-24       Impact factor: 4.772

10.  Multiple Basal Cell Carcinomas in Immunocompetent Patients.

Authors:  Paola Savoia; Federica Veronese; Lara Camillo; Vanessa Tarantino; Ottavio Cremona; Elisa Zavattaro
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.